

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | valine metabolic process (GO:0006573) | 5.91697250 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 5.59730941 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 5.18331067 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 4.98952606 |
| 5 | triglyceride catabolic process (GO:0019433) | 4.88509630 |
| 6 | fatty acid beta-oxidation (GO:0006635) | 4.86972579 |
| 7 | biotin metabolic process (GO:0006768) | 4.72892787 |
| 8 | branched-chain amino acid catabolic process (GO:0009083) | 4.71450666 |
| 9 | neutral lipid catabolic process (GO:0046461) | 4.65856811 |
| 10 | acylglycerol catabolic process (GO:0046464) | 4.65856811 |
| 11 | lysine catabolic process (GO:0006554) | 4.64536219 |
| 12 | lysine metabolic process (GO:0006553) | 4.64536219 |
| 13 | branched-chain amino acid metabolic process (GO:0009081) | 4.62757380 |
| 14 | fatty acid oxidation (GO:0019395) | 4.56935823 |
| 15 | NADH metabolic process (GO:0006734) | 4.51818349 |
| 16 | lipid oxidation (GO:0034440) | 4.48672460 |
| 17 | fatty acid catabolic process (GO:0009062) | 4.40265705 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.30971014 |
| 19 | brown fat cell differentiation (GO:0050873) | 4.19804551 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.18139828 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 4.18139828 |
| 22 | 2-oxoglutarate metabolic process (GO:0006103) | 4.16848797 |
| 23 | tricarboxylic acid metabolic process (GO:0072350) | 4.13308762 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 4.10395089 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.10395089 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 4.09414692 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.05037347 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 3.99457813 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 3.95774046 |
| 30 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.89449530 |
| 31 | thioester biosynthetic process (GO:0035384) | 3.88649034 |
| 32 | acyl-CoA biosynthetic process (GO:0071616) | 3.88649034 |
| 33 | succinate metabolic process (GO:0006105) | 3.88130728 |
| 34 | monocarboxylic acid catabolic process (GO:0072329) | 3.87034938 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 3.86926984 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 3.84879146 |
| 37 | triglyceride biosynthetic process (GO:0019432) | 3.79889606 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 3.77696121 |
| 39 | white fat cell differentiation (GO:0050872) | 3.77428214 |
| 40 | cysteine metabolic process (GO:0006534) | 3.72231471 |
| 41 | regulation of cholesterol storage (GO:0010885) | 3.72146205 |
| 42 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.72138682 |
| 43 | oxaloacetate metabolic process (GO:0006107) | 3.71731803 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 3.68160010 |
| 45 | neutral lipid biosynthetic process (GO:0046460) | 3.67990919 |
| 46 | acylglycerol biosynthetic process (GO:0046463) | 3.67990919 |
| 47 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.67391514 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.64079316 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.63000713 |
| 50 | carnitine metabolic process (GO:0009437) | 3.62810230 |
| 51 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.59303983 |
| 52 | regulation of fatty acid oxidation (GO:0046320) | 3.54041780 |
| 53 | triglyceride homeostasis (GO:0070328) | 3.52361002 |
| 54 | acylglycerol homeostasis (GO:0055090) | 3.52361002 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.51935142 |
| 56 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.51344245 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.49564873 |
| 58 | negative regulation of cell killing (GO:0031342) | 3.48700828 |
| 59 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48700828 |
| 60 | carnitine shuttle (GO:0006853) | 3.47466985 |
| 61 | triglyceride metabolic process (GO:0006641) | 3.46996608 |
| 62 | glycerolipid catabolic process (GO:0046503) | 3.46170042 |
| 63 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.39320355 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.37931398 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.36740485 |
| 66 | lipid particle organization (GO:0034389) | 3.35380671 |
| 67 | aspartate family amino acid catabolic process (GO:0009068) | 3.33693446 |
| 68 | COPI coating of Golgi vesicle (GO:0048205) | 3.33068767 |
| 69 | Golgi transport vesicle coating (GO:0048200) | 3.33068767 |
| 70 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.33066287 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.32430948 |
| 72 | glyoxylate metabolic process (GO:0046487) | 3.30691569 |
| 73 | acylglycerol metabolic process (GO:0006639) | 3.29606268 |
| 74 | neutral lipid metabolic process (GO:0006638) | 3.26380307 |
| 75 | regulation of fibrinolysis (GO:0051917) | 3.25930227 |
| 76 | acyl-CoA metabolic process (GO:0006637) | 3.25709368 |
| 77 | thioester metabolic process (GO:0035383) | 3.25709368 |
| 78 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.23118355 |
| 79 | carboxylic acid catabolic process (GO:0046395) | 3.18633423 |
| 80 | organic acid catabolic process (GO:0016054) | 3.18633423 |
| 81 | regulation of cholesterol esterification (GO:0010872) | 3.17349927 |
| 82 | regulation of protein activation cascade (GO:2000257) | 3.16810650 |
| 83 | fatty acid homeostasis (GO:0055089) | 3.16115508 |
| 84 | amino-acid betaine transport (GO:0015838) | 3.12761631 |
| 85 | carnitine transport (GO:0015879) | 3.12761631 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10733023 |
| 87 | ethanol oxidation (GO:0006069) | 3.08591517 |
| 88 | protein localization to endosome (GO:0036010) | 3.06254606 |
| 89 | regulation of complement activation (GO:0030449) | 3.06143999 |
| 90 | protein retention in ER lumen (GO:0006621) | 3.03936904 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.03897823 |
| 92 | protein carboxylation (GO:0018214) | 3.03897823 |
| 93 | regulation of triglyceride metabolic process (GO:0090207) | 3.03104363 |
| 94 | pentose-phosphate shunt (GO:0006098) | 3.03037327 |
| 95 | carnitine transmembrane transport (GO:1902603) | 3.02159925 |
| 96 | NADPH regeneration (GO:0006740) | 3.00173517 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 2.99500445 |
| 98 | glucose 6-phosphate metabolic process (GO:0051156) | 2.98393094 |
| 99 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.96997660 |
| 100 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.96306383 |
| 101 | drug transmembrane transport (GO:0006855) | 2.95689089 |
| 102 | coenzyme A metabolic process (GO:0015936) | 2.95554450 |
| 103 | bile acid biosynthetic process (GO:0006699) | 2.95501978 |
| 104 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.94884326 |
| 105 | amino sugar catabolic process (GO:0046348) | 2.93151065 |
| 106 | quaternary ammonium group transport (GO:0015697) | 2.92769949 |
| 107 | alpha-amino acid catabolic process (GO:1901606) | 2.90392861 |
| 108 | cellular lipid catabolic process (GO:0044242) | 2.89989096 |
| 109 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88966320 |
| 110 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88966320 |
| 111 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.88109084 |
| 112 | ketone body metabolic process (GO:1902224) | 2.87683597 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87424203 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87424203 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 2.87324074 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87051303 |
| 117 | negative regulation of lipase activity (GO:0060192) | 2.86955448 |
| 118 | homocysteine metabolic process (GO:0050667) | 2.86412536 |
| 119 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.84193494 |
| 120 | glucose catabolic process (GO:0006007) | 2.83799189 |
| 121 | response to peptidoglycan (GO:0032494) | 2.81706892 |
| 122 | coenzyme A biosynthetic process (GO:0015937) | 2.81483104 |
| 123 | detection of other organism (GO:0098543) | 2.80359410 |
| 124 | lipid storage (GO:0019915) | 2.77572956 |
| 125 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.76534330 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 2.75480849 |
| 127 | neutrophil activation involved in immune response (GO:0002283) | 2.75334439 |
| 128 | acute-phase response (GO:0006953) | 2.75302443 |
| 129 | linoleic acid metabolic process (GO:0043651) | 2.75226959 |
| 130 | positive regulation of cholesterol efflux (GO:0010875) | 2.73176749 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.73104589 |
| 132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69705651 |
| 133 | regulation of superoxide anion generation (GO:0032928) | 2.66241052 |
| 134 | L-serine transport (GO:0015825) | 2.65637507 |
| 135 | positive regulation of hemostasis (GO:1900048) | 2.64936623 |
| 136 | positive regulation of blood coagulation (GO:0030194) | 2.64936623 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.63207603 |
| 138 | phospholipid efflux (GO:0033700) | 2.61855861 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.61598206 |
| 140 | positive regulation of coagulation (GO:0050820) | 2.60697955 |
| 141 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59855140 |
| 142 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.59776922 |
| 143 | detection of bacterium (GO:0016045) | 2.59662545 |
| 144 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.59237993 |
| 145 | signal complex assembly (GO:0007172) | 2.59230355 |
| 146 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.58963441 |
| 147 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.58096089 |
| 148 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.58096089 |
| 149 | cholesterol efflux (GO:0033344) | 2.53599798 |
| 150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.51727256 |
| 151 | fibrinolysis (GO:0042730) | 2.51701846 |
| 152 | regulation of mast cell degranulation (GO:0043304) | 2.50463388 |
| 153 | urea metabolic process (GO:0019627) | 2.50175626 |
| 154 | low-density lipoprotein particle remodeling (GO:0034374) | 2.49525576 |
| 155 | protein maturation by protein folding (GO:0022417) | 2.49265682 |
| 156 | apoptotic cell clearance (GO:0043277) | 2.48554528 |
| 157 | regulation of apoptotic cell clearance (GO:2000425) | 2.48009333 |
| 158 | serine transport (GO:0032329) | 2.47633087 |
| 159 | regulation of macrophage chemotaxis (GO:0010758) | 2.47348418 |
| 160 | regulation of activation of Janus kinase activity (GO:0010533) | 2.47348112 |
| 161 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46924644 |
| 162 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.46488091 |
| 163 | regulation of plasminogen activation (GO:0010755) | 2.46203452 |
| 164 | nitrogen cycle metabolic process (GO:0071941) | 2.45891588 |
| 165 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.45792402 |
| 166 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44626223 |
| 167 | urea cycle (GO:0000050) | 2.44152477 |
| 168 | positive regulation of phagocytosis (GO:0050766) | 2.44069389 |
| 169 | amyloid precursor protein catabolic process (GO:0042987) | 2.43801453 |
| 170 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.42672438 |
| 171 | positive regulation of sterol transport (GO:0032373) | 2.42452023 |
| 172 | positive regulation of cholesterol transport (GO:0032376) | 2.42452023 |
| 173 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.42161429 |
| 174 | pentose metabolic process (GO:0019321) | 2.42081961 |
| 175 | pinocytosis (GO:0006907) | 2.41332321 |
| 176 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.41013025 |
| 177 | plasma lipoprotein particle assembly (GO:0034377) | 2.40329904 |
| 178 | detection of biotic stimulus (GO:0009595) | 2.40260568 |
| 179 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.38610248 |
| 180 | granulocyte activation (GO:0036230) | 2.38296926 |
| 181 | regulation of phagocytosis (GO:0050764) | 2.35850361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.88942993 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.13487027 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.94052497 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.34133118 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18827977 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87256105 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.52633139 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31971251 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.14652488 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69943947 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60346244 |
| 12 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.58653897 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.54562302 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.43774899 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.11247428 |
| 16 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05821632 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05607553 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.6096197 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92345510 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90129867 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89387831 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87558101 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81929556 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80499034 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65155645 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64625656 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62681094 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58918318 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57091245 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50897358 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50149271 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49860508 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.49039407 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46161434 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45489637 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44605354 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43626910 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42749607 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41462843 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40797982 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40646827 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38982047 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37707225 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35361756 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34540127 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33875985 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33071863 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32875956 |
| 49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30675299 |
| 50 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.30423991 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26790046 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26736076 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26446931 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24839929 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23117704 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22634533 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20445513 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18788192 |
| 59 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.17561781 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17236316 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16168770 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15917584 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15669495 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.14768174 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13960170 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12661906 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11730955 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11704709 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11094240 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10718219 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10186389 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09838790 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09785665 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09280075 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.08493071 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07996854 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07958327 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07547333 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07408738 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07341726 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06428554 |
| 82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06066342 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06036530 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05193547 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05131483 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04630306 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04511556 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04511556 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03740659 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03722841 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.03465840 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03302228 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03165887 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02347562 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01490556 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01399434 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01096727 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00871640 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00771749 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00588765 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00122214 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99656038 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99653817 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99084028 |
| 105 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98540593 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97616434 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96913873 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96705020 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95297741 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95077006 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94808479 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94682658 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94268824 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94035263 |
| 115 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93441898 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92192247 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92192247 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90517199 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88516920 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88130063 |
| 121 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86470734 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82213572 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79695741 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79285788 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78334418 |
| 126 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76537677 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75880060 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.72350031 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71678560 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71651713 |
| 131 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70621186 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69818938 |
| 133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68859353 |
| 134 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68703993 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68352315 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67430817 |
| 137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66530951 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65859062 |
| 139 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.65178028 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63905655 |
| 141 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.63884047 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63802441 |
| 143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63341951 |
| 144 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.61354461 |
| 145 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.61330886 |
| 146 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.61199079 |
| 147 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.60266290 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59963761 |
| 149 | CBP_21632823_ChIP-Seq_H3396_Human | 0.58668702 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58427747 |
| 151 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.58186521 |
| 152 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57911204 |
| 153 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57467806 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57362243 |
| 155 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57000038 |
| 156 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.56970793 |
| 157 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.56202746 |
| 158 | CJUN_26792858_Chip-Seq_BT549_Human | 0.55486518 |
| 159 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55065535 |
| 160 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53985859 |
| 161 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.53222765 |
| 162 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.52785934 |
| 163 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.52390083 |
| 164 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.52184671 |
| 165 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.52184671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.74357451 |
| 2 | MP0005670_abnormal_white_adipose | 4.74326465 |
| 3 | MP0005360_urolithiasis | 4.15030837 |
| 4 | MP0004130_abnormal_muscle_cell | 3.72279392 |
| 5 | MP0005365_abnormal_bile_salt | 3.70930365 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.30407742 |
| 7 | MP0005666_abnormal_adipose_tissue | 3.24722830 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.95853685 |
| 9 | MP0003436_decreased_susceptibility_to | 2.91542144 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.76791796 |
| 11 | MP0006082_CNS_inflammation | 2.76170229 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.75093031 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.69319107 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.68642628 |
| 15 | MP0008260_abnormal_autophagy | 2.65695683 |
| 16 | MP0005332_abnormal_amino_acid | 2.50048949 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44751374 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.43990547 |
| 19 | MP0002971_abnormal_brown_adipose | 2.37004220 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.36706797 |
| 21 | MP0002419_abnormal_innate_immunity | 2.29535868 |
| 22 | MP0009785_altered_susceptibility_to | 2.24333573 |
| 23 | MP0002876_abnormal_thyroid_physiology | 2.14047712 |
| 24 | MP0000858_altered_metastatic_potential | 2.10390626 |
| 25 | MP0005535_abnormal_body_temperature | 2.03650115 |
| 26 | MP0005025_abnormal_response_to | 2.02816520 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.99601581 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.97382743 |
| 29 | MP0005451_abnormal_body_composition | 1.88216981 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.85935002 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.80748764 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.80231969 |
| 33 | MP0003195_calcinosis | 1.79705111 |
| 34 | MP0005334_abnormal_fat_pad | 1.79691932 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.78859831 |
| 36 | MP0000609_abnormal_liver_physiology | 1.77030168 |
| 37 | MP0005671_abnormal_response_to | 1.76611485 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.76202067 |
| 39 | MP0001661_extended_life_span | 1.73919756 |
| 40 | MP0003252_abnormal_bile_duct | 1.72763842 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.71696011 |
| 42 | MP0003303_peritoneal_inflammation | 1.68103352 |
| 43 | MP0003186_abnormal_redox_activity | 1.64631892 |
| 44 | MP0009840_abnormal_foam_cell | 1.62390498 |
| 45 | MP0000685_abnormal_immune_system | 1.61534058 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.61354546 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.58231082 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.55771602 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.55052405 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.54792451 |
| 51 | MP0001853_heart_inflammation | 1.52910585 |
| 52 | MP0004043_abnormal_pH_regulation | 1.52221174 |
| 53 | MP0009115_abnormal_fat_cell | 1.51804228 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.51134519 |
| 55 | MP0001756_abnormal_urination | 1.45744083 |
| 56 | MP0003724_increased_susceptibility_to | 1.43464558 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.42376570 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.42314217 |
| 59 | MP0001764_abnormal_homeostasis | 1.41102827 |
| 60 | MP0002970_abnormal_white_adipose | 1.40861955 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.40693991 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.40520406 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.38880636 |
| 64 | MP0004947_skin_inflammation | 1.36372955 |
| 65 | MP0004147_increased_porphyrin_level | 1.34158104 |
| 66 | MP0000920_abnormal_myelination | 1.32858658 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.29478879 |
| 68 | MP0005448_abnormal_energy_balance | 1.28822078 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.27462098 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.26489627 |
| 71 | MP0003011_delayed_dark_adaptation | 1.25537278 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.24864401 |
| 73 | MP0002723_abnormal_immune_serum | 1.24816380 |
| 74 | MP0001790_abnormal_immune_system | 1.23815365 |
| 75 | MP0005387_immune_system_phenotype | 1.23815365 |
| 76 | MP0003690_abnormal_glial_cell | 1.23363300 |
| 77 | MP0003329_amyloid_beta_deposits | 1.23230395 |
| 78 | MP0003959_abnormal_lean_body | 1.21156663 |
| 79 | MP0000604_amyloidosis | 1.20815167 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.20274578 |
| 81 | MP0008961_abnormal_basal_metabolism | 1.20177187 |
| 82 | MP0003448_altered_tumor_morphology | 1.18527386 |
| 83 | MP0002420_abnormal_adaptive_immunity | 1.18508057 |
| 84 | MP0001819_abnormal_immune_cell | 1.17430411 |
| 85 | MP0004883_abnormal_blood_vessel | 1.15467382 |
| 86 | MP0009764_decreased_sensitivity_to | 1.13295173 |
| 87 | MP0005275_abnormal_skin_tensile | 1.12689747 |
| 88 | MP0002452_abnormal_antigen_presenting | 1.09983362 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 1.09484925 |
| 90 | MP0002405_respiratory_system_inflammati | 1.07041550 |
| 91 | MP0001765_abnormal_ion_homeostasis | 1.04538188 |
| 92 | MP0000230_abnormal_systemic_arterial | 1.03963765 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.02663138 |
| 94 | MP0005452_abnormal_adipose_tissue | 1.00208206 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.98157844 |
| 96 | MP0004272_abnormal_basement_membrane | 0.97375325 |
| 97 | MP0005083_abnormal_biliary_tract | 0.96840484 |
| 98 | MP0003122_maternal_imprinting | 0.96802955 |
| 99 | MP0005165_increased_susceptibility_to | 0.95311207 |
| 100 | MP0003953_abnormal_hormone_level | 0.94143650 |
| 101 | MP0005023_abnormal_wound_healing | 0.93542933 |
| 102 | MP0002132_abnormal_respiratory_system | 0.92252077 |
| 103 | MP0005257_abnormal_intraocular_pressure | 0.90609026 |
| 104 | MP0001958_emphysema | 0.89347848 |
| 105 | MP0000751_myopathy | 0.87184144 |
| 106 | MP0001800_abnormal_humoral_immune | 0.86943885 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.86827723 |
| 108 | MP0003646_muscle_fatigue | 0.86813831 |
| 109 | MP0005408_hypopigmentation | 0.85366224 |
| 110 | MP0001915_intracranial_hemorrhage | 0.83448513 |
| 111 | MP0004858_abnormal_nervous_system | 0.83121398 |
| 112 | MP0003878_abnormal_ear_physiology | 0.83086283 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.83086283 |
| 114 | MP0005166_decreased_susceptibility_to | 0.82197335 |
| 115 | MP0001851_eye_inflammation | 0.81678390 |
| 116 | MP0006138_congestive_heart_failure | 0.81637636 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.81238766 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.80452744 |
| 119 | MP0001881_abnormal_mammary_gland | 0.80365313 |
| 120 | MP0005330_cardiomyopathy | 0.78719845 |
| 121 | MP0005164_abnormal_response_to | 0.78599238 |
| 122 | MP0003866_abnormal_defecation | 0.78463090 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.77534741 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.76370168 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.76353429 |
| 126 | MP0005390_skeleton_phenotype | 0.75520038 |
| 127 | MP0001542_abnormal_bone_strength | 0.75236732 |
| 128 | MP0003879_abnormal_hair_cell | 0.75028096 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.73839690 |
| 130 | MP0000716_abnormal_immune_system | 0.73338068 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.72791335 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.72416672 |
| 133 | MP0000598_abnormal_liver_morphology | 0.72148768 |
| 134 | MP0003795_abnormal_bone_structure | 0.70359313 |
| 135 | MP0003634_abnormal_glial_cell | 0.69981722 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.68980220 |
| 137 | MP0009763_increased_sensitivity_to | 0.68059661 |
| 138 | MP0001944_abnormal_pancreas_morphology | 0.66367316 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64934577 |
| 140 | MP0002796_impaired_skin_barrier | 0.63578664 |
| 141 | MP0003075_altered_response_to | 0.62481173 |
| 142 | MP0000343_altered_response_to | 0.61462468 |
| 143 | MP0001544_abnormal_cardiovascular_syste | 0.61235460 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.61235460 |
| 145 | MP0002090_abnormal_vision | 0.60687815 |
| 146 | MP0000747_muscle_weakness | 0.60050790 |
| 147 | MP0008469_abnormal_protein_level | 0.59335531 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.59306525 |
| 149 | MP0002069_abnormal_eating/drinking_beha | 0.58997992 |
| 150 | MP0003633_abnormal_nervous_system | 0.57953001 |
| 151 | MP0003868_abnormal_feces_composition | 0.57234083 |
| 152 | MP0005620_abnormal_muscle_contractility | 0.56932034 |
| 153 | MP0002269_muscular_atrophy | 0.56531684 |
| 154 | MP0004215_abnormal_myocardial_fiber | 0.55923109 |
| 155 | MP0001177_atelectasis | 0.55260342 |
| 156 | MP0002168_other_aberrant_phenotype | 0.54291836 |
| 157 | MP0002138_abnormal_hepatobiliary_system | 0.53682514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.14529456 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.14529456 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.14529456 |
| 4 | Hyperglycinuria (HP:0003108) | 4.87286851 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.68964450 |
| 6 | Ketoacidosis (HP:0001993) | 4.63750327 |
| 7 | Ketosis (HP:0001946) | 4.61132133 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.46912413 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.46912413 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.36909336 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.34988179 |
| 12 | Oligomenorrhea (HP:0000876) | 4.24255954 |
| 13 | Xanthomatosis (HP:0000991) | 3.99223866 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.89688010 |
| 15 | Hyperammonemia (HP:0001987) | 3.81521032 |
| 16 | Complement deficiency (HP:0004431) | 3.65494593 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.62916843 |
| 18 | Hyperglycinemia (HP:0002154) | 3.58643562 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.57253879 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56984503 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.56918864 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53433898 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.45554161 |
| 24 | Orchitis (HP:0100796) | 3.44405436 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.42698231 |
| 26 | Dicarboxylic aciduria (HP:0003215) | 3.42698231 |
| 27 | Hypertriglyceridemia (HP:0002155) | 3.40064675 |
| 28 | Glomerulonephritis (HP:0000099) | 3.32236846 |
| 29 | Generalized aminoaciduria (HP:0002909) | 3.30830864 |
| 30 | Myositis (HP:0100614) | 3.28996618 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.26760817 |
| 32 | Purpura (HP:0000979) | 3.20832292 |
| 33 | Vertebral compression fractures (HP:0002953) | 3.20548372 |
| 34 | Myoglobinuria (HP:0002913) | 3.16608081 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 3.14091727 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.13477771 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.13477771 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.13477771 |
| 39 | Gout (HP:0001997) | 3.08817201 |
| 40 | Acanthosis nigricans (HP:0000956) | 3.07038819 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.06175461 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.01461487 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 3.00994353 |
| 44 | Deep venous thrombosis (HP:0002625) | 3.00037062 |
| 45 | Optic neuritis (HP:0100653) | 2.99612389 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.99612389 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.99303518 |
| 48 | Amyloidosis (HP:0011034) | 2.98726257 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.95325568 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.88973490 |
| 51 | Joint hemorrhage (HP:0005261) | 2.87178672 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.86666531 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.86666531 |
| 54 | Intrahepatic cholestasis (HP:0001406) | 2.85046438 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.78778966 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.78531940 |
| 57 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.74517947 |
| 58 | Epidermoid cyst (HP:0200040) | 2.72135962 |
| 59 | Hyperuricemia (HP:0002149) | 2.69403345 |
| 60 | Increased purine levels (HP:0004368) | 2.69403345 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.65647087 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.62560222 |
| 63 | Hepatic necrosis (HP:0002605) | 2.62064521 |
| 64 | Metabolic acidosis (HP:0001942) | 2.60779457 |
| 65 | Loss of speech (HP:0002371) | 2.58210903 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.53540275 |
| 67 | Axonal loss (HP:0003447) | 2.52941426 |
| 68 | Pancreatitis (HP:0001733) | 2.52671966 |
| 69 | Gingival bleeding (HP:0000225) | 2.51359649 |
| 70 | Vomiting (HP:0002013) | 2.50217938 |
| 71 | Lethargy (HP:0001254) | 2.47563249 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47002880 |
| 73 | Abnormality of complement system (HP:0005339) | 2.46320925 |
| 74 | Nausea (HP:0002018) | 2.43196991 |
| 75 | Cerebral edema (HP:0002181) | 2.41669384 |
| 76 | J-shaped sella turcica (HP:0002680) | 2.41107162 |
| 77 | Upper motor neuron abnormality (HP:0002127) | 2.38549995 |
| 78 | Growth hormone excess (HP:0000845) | 2.38243633 |
| 79 | Skin nodule (HP:0200036) | 2.35853762 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.35481851 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.32888492 |
| 82 | Hepatosplenomegaly (HP:0001433) | 2.32433801 |
| 83 | Insulin resistance (HP:0000855) | 2.30734120 |
| 84 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30664477 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28120801 |
| 86 | Mitral stenosis (HP:0001718) | 2.27156175 |
| 87 | Brushfield spots (HP:0001088) | 2.26551141 |
| 88 | Myocardial infarction (HP:0001658) | 2.25657450 |
| 89 | Mutism (HP:0002300) | 2.24953758 |
| 90 | Hypokalemic alkalosis (HP:0001949) | 2.24256778 |
| 91 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23354479 |
| 92 | Peritonitis (HP:0002586) | 2.23100105 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.22479893 |
| 94 | Pheochromocytoma (HP:0002666) | 2.19340878 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 2.19258943 |
| 96 | Methylmalonic aciduria (HP:0012120) | 2.16805092 |
| 97 | Glomerulopathy (HP:0100820) | 2.16641491 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.14767587 |
| 99 | Nephritis (HP:0000123) | 2.14585430 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.14467950 |
| 101 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13035255 |
| 102 | Obstructive lung disease (HP:0006536) | 2.13035255 |
| 103 | Rhabdomyolysis (HP:0003201) | 2.12636991 |
| 104 | Increased IgM level (HP:0003496) | 2.12439810 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.11294862 |
| 106 | Conjunctival hamartoma (HP:0100780) | 2.10823093 |
| 107 | Hyperglycemia (HP:0003074) | 2.10560110 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 2.08730355 |
| 109 | Gingivitis (HP:0000230) | 2.07222722 |
| 110 | Pathologic fracture (HP:0002756) | 2.06940420 |
| 111 | Abnormality of the intrinsic pathway (HP:0010989) | 2.06890565 |
| 112 | Hypobetalipoproteinemia (HP:0003563) | 2.05761421 |
| 113 | Tachypnea (HP:0002789) | 2.03688385 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 2.02232025 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 2.02046347 |
| 116 | Hypercholesterolemia (HP:0003124) | 2.00409792 |
| 117 | Premature rupture of membranes (HP:0001788) | 2.00052909 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.99731691 |
| 119 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99116040 |
| 120 | Protrusio acetabuli (HP:0003179) | 1.98803391 |
| 121 | Pulmonary embolism (HP:0002204) | 1.98554782 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 1.97474653 |
| 123 | Bone cyst (HP:0012062) | 1.96472366 |
| 124 | Recurrent skin infections (HP:0001581) | 1.95468592 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94764230 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 1.94604123 |
| 127 | Cholecystitis (HP:0001082) | 1.94599999 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.94599999 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.94211742 |
| 130 | Neoplasm of the adrenal gland (HP:0100631) | 1.92177243 |
| 131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92146113 |
| 132 | Acute encephalopathy (HP:0006846) | 1.91622391 |
| 133 | Increased IgE level (HP:0003212) | 1.90833300 |
| 134 | Supranuclear gaze palsy (HP:0000605) | 1.90792511 |
| 135 | Gastrointestinal infarctions (HP:0005244) | 1.89604590 |
| 136 | Neuroendocrine neoplasm (HP:0100634) | 1.88664097 |
| 137 | Abnormality of alanine metabolism (HP:0010916) | 1.87072356 |
| 138 | Hyperalaninemia (HP:0003348) | 1.87072356 |
| 139 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87072356 |
| 140 | Increased serum ferritin (HP:0003281) | 1.86452253 |
| 141 | Late onset (HP:0003584) | 1.86196673 |
| 142 | Hand muscle atrophy (HP:0009130) | 1.85383271 |
| 143 | Encephalitis (HP:0002383) | 1.85288750 |
| 144 | Achilles tendon contracture (HP:0001771) | 1.84859517 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.84525364 |
| 146 | Hyperbilirubinemia (HP:0002904) | 1.84016709 |
| 147 | Neonatal onset (HP:0003623) | 1.83367479 |
| 148 | Hyperactive renin-angiotensin system (HP:0000841) | 1.82688853 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.81734157 |
| 150 | Increased serum pyruvate (HP:0003542) | 1.81443308 |
| 151 | Abnormality of glycolysis (HP:0004366) | 1.81443308 |
| 152 | Epistaxis (HP:0000421) | 1.81209897 |
| 153 | Meningitis (HP:0001287) | 1.80305236 |
| 154 | Cerebral hemorrhage (HP:0001342) | 1.78553999 |
| 155 | Menorrhagia (HP:0000132) | 1.78418600 |
| 156 | Petechiae (HP:0000967) | 1.78291646 |
| 157 | Cerebral aneurysm (HP:0004944) | 1.76886423 |
| 158 | Hepatocellular necrosis (HP:0001404) | 1.75237366 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74965627 |
| 160 | Mucopolysacchariduria (HP:0008155) | 1.74965627 |
| 161 | Distal upper limb amyotrophy (HP:0007149) | 1.73411816 |
| 162 | Upper limb amyotrophy (HP:0009129) | 1.73411816 |
| 163 | Arterial thrombosis (HP:0004420) | 1.72625202 |
| 164 | Joint swelling (HP:0001386) | 1.72505596 |
| 165 | Acute hepatic failure (HP:0006554) | 1.71694647 |
| 166 | Hypergammaglobulinemia (HP:0010702) | 1.71278500 |
| 167 | Nuclear cataract (HP:0100018) | 1.70645159 |
| 168 | Epiphyseal stippling (HP:0010655) | 1.70026728 |
| 169 | Irritability (HP:0000737) | 1.69971268 |
| 170 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68898987 |
| 171 | Gangrene (HP:0100758) | 1.68282076 |
| 172 | Keratoconjunctivitis (HP:0001096) | 1.68225451 |
| 173 | Hemorrhage of the eye (HP:0011885) | 1.67308840 |
| 174 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.66810604 |
| 175 | Global brain atrophy (HP:0002283) | 1.66809510 |
| 176 | Urticaria (HP:0001025) | 1.66193151 |
| 177 | Lactic acidosis (HP:0003128) | 1.66010964 |
| 178 | Tetraparesis (HP:0002273) | 1.64805392 |
| 179 | Tetraplegia (HP:0002445) | 1.64625952 |
| 180 | Thrombophlebitis (HP:0004418) | 1.63919219 |
| 181 | Alkalosis (HP:0001948) | 1.63396238 |
| 182 | Abnormality of urine glucose concentration (HP:0011016) | 1.62985681 |
| 183 | Glycosuria (HP:0003076) | 1.62985681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.30193481 |
| 2 | TRIB3 | 4.37911733 |
| 3 | ERN1 | 4.17826899 |
| 4 | SIK1 | 3.47460789 |
| 5 | CAMK1D | 3.41477827 |
| 6 | TESK2 | 3.26266356 |
| 7 | TESK1 | 2.43291683 |
| 8 | PDK4 | 2.39855583 |
| 9 | PDK3 | 2.39855583 |
| 10 | CAMK1G | 2.25371509 |
| 11 | EPHA3 | 2.22938622 |
| 12 | TXK | 2.20627497 |
| 13 | MAP3K11 | 2.17717984 |
| 14 | PKN2 | 2.09219366 |
| 15 | CAMKK2 | 2.00555067 |
| 16 | LMTK2 | 1.89886572 |
| 17 | INSRR | 1.80045912 |
| 18 | MAP4K1 | 1.79068836 |
| 19 | IRAK4 | 1.70476716 |
| 20 | FGFR4 | 1.63862138 |
| 21 | WNK4 | 1.60166587 |
| 22 | CSK | 1.56869354 |
| 23 | TIE1 | 1.54153985 |
| 24 | SIK2 | 1.52956785 |
| 25 | OXSR1 | 1.50647999 |
| 26 | LIMK1 | 1.46411649 |
| 27 | FES | 1.44870529 |
| 28 | ZAP70 | 1.42975223 |
| 29 | BLK | 1.40153852 |
| 30 | NTRK3 | 1.39052123 |
| 31 | MST1R | 1.38833700 |
| 32 | KSR2 | 1.38470199 |
| 33 | EPHA2 | 1.36902502 |
| 34 | GRK6 | 1.36345135 |
| 35 | PRPF4B | 1.35585092 |
| 36 | PAK4 | 1.35316581 |
| 37 | PDK2 | 1.31912218 |
| 38 | WNK3 | 1.29440463 |
| 39 | MAP2K4 | 1.26541572 |
| 40 | NME2 | 1.24269581 |
| 41 | FLT3 | 1.19094584 |
| 42 | MAP2K1 | 1.18976741 |
| 43 | DAPK2 | 1.18879719 |
| 44 | NTRK1 | 1.17991983 |
| 45 | SIK3 | 1.16312140 |
| 46 | RIPK1 | 1.15502434 |
| 47 | TAOK2 | 1.14892786 |
| 48 | FRK | 1.12414474 |
| 49 | PRKAA2 | 1.08696719 |
| 50 | RIPK4 | 1.08054982 |
| 51 | PDPK1 | 1.07393846 |
| 52 | RET | 1.07284841 |
| 53 | SCYL2 | 1.00155514 |
| 54 | KDR | 0.99793367 |
| 55 | FGR | 0.99636396 |
| 56 | TGFBR2 | 0.97715559 |
| 57 | MAPKAPK3 | 0.97561647 |
| 58 | CAMKK1 | 0.96856581 |
| 59 | TAOK1 | 0.95977391 |
| 60 | JAK2 | 0.95660839 |
| 61 | PINK1 | 0.95459813 |
| 62 | FER | 0.93153167 |
| 63 | PIM2 | 0.92146809 |
| 64 | MAP3K2 | 0.91927030 |
| 65 | PDK1 | 0.91072852 |
| 66 | CSF1R | 0.89485228 |
| 67 | MOS | 0.86614651 |
| 68 | JAK1 | 0.83436388 |
| 69 | MYLK | 0.82621399 |
| 70 | MAP3K14 | 0.80709073 |
| 71 | SMG1 | 0.79526045 |
| 72 | PDGFRA | 0.79189501 |
| 73 | PRKCH | 0.78736451 |
| 74 | GRK7 | 0.74286819 |
| 75 | MAP3K13 | 0.73970662 |
| 76 | GRK5 | 0.72570005 |
| 77 | PTK2 | 0.70630969 |
| 78 | JAK3 | 0.69380324 |
| 79 | FGFR2 | 0.69132169 |
| 80 | LRRK2 | 0.67837249 |
| 81 | PRKD2 | 0.66692895 |
| 82 | DAPK1 | 0.65855100 |
| 83 | MAPK11 | 0.65292771 |
| 84 | MINK1 | 0.64736350 |
| 85 | PRKAA1 | 0.64184968 |
| 86 | ABL2 | 0.63554553 |
| 87 | HCK | 0.63340191 |
| 88 | MAP3K6 | 0.63327987 |
| 89 | IRAK3 | 0.62960688 |
| 90 | PRKACG | 0.62270660 |
| 91 | STK38 | 0.62137771 |
| 92 | FGFR3 | 0.59953941 |
| 93 | DYRK1B | 0.59892847 |
| 94 | EPHA4 | 0.58972639 |
| 95 | FYN | 0.58965562 |
| 96 | MAP3K9 | 0.58066682 |
| 97 | NEK1 | 0.57494298 |
| 98 | MAP3K12 | 0.55980492 |
| 99 | ICK | 0.55407091 |
| 100 | MAP3K1 | 0.55226280 |
| 101 | SGK494 | 0.55176991 |
| 102 | SGK223 | 0.55176991 |
| 103 | ARAF | 0.54925501 |
| 104 | MAP2K6 | 0.54786135 |
| 105 | LCK | 0.54705202 |
| 106 | TYK2 | 0.54321099 |
| 107 | MAP3K5 | 0.52346210 |
| 108 | CDK9 | 0.50657033 |
| 109 | SGK3 | 0.50644147 |
| 110 | MAPKAPK2 | 0.50354314 |
| 111 | IGF1R | 0.49914075 |
| 112 | TYRO3 | 0.49316209 |
| 113 | PIK3CG | 0.47944798 |
| 114 | EPHB2 | 0.47780393 |
| 115 | PTK6 | 0.46014910 |
| 116 | IKBKB | 0.45879005 |
| 117 | PRKCD | 0.45328296 |
| 118 | GSK3A | 0.45319729 |
| 119 | CDK5 | 0.45235104 |
| 120 | RPS6KA2 | 0.44843997 |
| 121 | PAK6 | 0.44121614 |
| 122 | PRKCI | 0.43690127 |
| 123 | CAMK1 | 0.43631461 |
| 124 | MAP3K7 | 0.43362206 |
| 125 | LYN | 0.42483490 |
| 126 | MATK | 0.42335788 |
| 127 | TNK2 | 0.42217811 |
| 128 | CDK19 | 0.42212333 |
| 129 | ILK | 0.42134039 |
| 130 | CDC42BPA | 0.41323508 |
| 131 | SRC | 0.40863946 |
| 132 | TTN | 0.39802865 |
| 133 | PRKCZ | 0.39739510 |
| 134 | MARK2 | 0.38216359 |
| 135 | EEF2K | 0.38167230 |
| 136 | MAPK12 | 0.38133722 |
| 137 | KSR1 | 0.37434526 |
| 138 | TAOK3 | 0.37172473 |
| 139 | STK39 | 0.37079131 |
| 140 | CDK6 | 0.36778209 |
| 141 | TBK1 | 0.35984752 |
| 142 | PAK3 | 0.35676492 |
| 143 | MAPK4 | 0.34748158 |
| 144 | LATS1 | 0.33808159 |
| 145 | IRAK1 | 0.32892681 |
| 146 | EPHB1 | 0.32513789 |
| 147 | PRKG2 | 0.32251276 |
| 148 | RAF1 | 0.30661247 |
| 149 | SGK2 | 0.30558493 |
| 150 | NEK9 | 0.30231232 |
| 151 | MAP3K3 | 0.28597141 |
| 152 | MAP2K3 | 0.28462946 |
| 153 | RPS6KB1 | 0.27856351 |
| 154 | PDGFRB | 0.27791147 |
| 155 | PRKD1 | 0.27358477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.65305191 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.50554293 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.41452708 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.15075544 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02353458 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.97558282 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.88069039 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71978827 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50177953 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.40505717 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38322927 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28324764 |
| 13 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.23707423 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.20892515 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.15014486 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07360148 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96172717 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89429316 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.87342053 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84089975 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76134062 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72395674 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71871938 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67080418 |
| 25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.66646295 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65287513 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64658148 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.58730579 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56311861 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51160899 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47069210 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.41149902 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40675221 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38008379 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.35201340 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.34429880 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30447857 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29358355 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22184432 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.21750442 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20143388 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17415656 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17033344 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16564694 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14791952 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09602633 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09327997 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07585100 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03865177 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.03746873 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03717760 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03713686 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03421350 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.03228234 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00782045 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.99213346 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97283383 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95878779 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95028676 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94696498 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.93895270 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91382557 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90755206 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86335406 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84912279 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83264660 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83195568 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.81971304 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80924960 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79131976 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77879104 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76663419 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74471265 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74242735 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73949378 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.73824888 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71089519 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67516381 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.63364708 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.63243699 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.61642986 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60913357 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60896358 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.59972458 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59438970 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58451686 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.58313896 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57546896 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56756363 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55841181 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55754024 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55155590 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53190541 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53032206 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52047984 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52008830 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50435564 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.49115327 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48633271 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48331028 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46502322 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46317416 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46019788 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45539144 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44917561 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44292479 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.43732481 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43044613 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42922314 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42799851 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42024529 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41945773 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41470536 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41187912 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40921624 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40381950 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38718808 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37773094 |
| 119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37197037 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36770600 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36520355 |
| 122 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36491952 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36061406 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35835294 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35695255 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35388397 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32596369 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.32522617 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31863830 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30956330 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30611507 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29791150 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27498728 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27063172 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26898374 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24362639 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23496841 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23007255 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22519465 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22255181 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21601971 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20435894 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19568059 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18628476 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.16565757 |
| 146 | Protein export_Homo sapiens_hsa03060 | 0.12776746 |

